NCT00532272View on ClinicalTrials.gov

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

August 31, 2010

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Letrozole ,Goserelin

Letrozole 2.5mg qd. Goserlin 3.6mg monthly(premenopausal)

Trial Locations (1)

Unknown

National Cancer Center, Goyang

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT00532272 - Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | Biotech Hunter | Biotech Hunter